RETRACTED ARTICLE: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis

RETRACTED ARTICLE: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis

Abstract Background Anti-angiogenesis remains an attractive strategy for cancer therapy. Some anti-angiogenic reagents have bell-shape dose-response curves with higher than the effective doses yielding lower anti-angiogenic effects. In this study, two different types of anti-angiogenic reagents, a r...

Full description

Bibliographic Details
Main Authors: Jialiang Hu, Wenjing Wang, Chen Liu, Mengwei Li, Edouard Nice, Hanmei Xu
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Tumor metastasis
Angiogenesis
Integrins
Cell migration
RhoGTPase
Lipid rafts
Online Access:http://link.springer.com/article/10.1186/s13046-019-1324-7

Internet

http://link.springer.com/article/10.1186/s13046-019-1324-7

Similar Items